Logotipo del repositorio
Logotipo del repositorio
 

Una visión acerca de la Leishmaniasis americana y de su comportamiento epidemiológico

Vista sencilla de ítem
dc.contributor.authorIsaza-Jaimes, Angelica
dc.contributor.authorRodríguez, Johel E
dc.contributor.authorChacón, Gerardo
dc.contributor.authorBravo, Antonio
dc.contributor.authorSilva Sarabia, Christian
dc.date.accessioned2018-10-03T22:28:36Z
dc.date.available2018-10-03T22:28:36Z
dc.date.issued2018
dc.description.abstractLa Leishmaniasis es una enfermedad causada por un parásito protozoario del género Leishmania. Es considerada una enfermedad autóctona de progresión lenta, y epidemiológicamente tratada en las Américas, como un trastorno parasitario transmitido por la picadura de un mosquito hematófago infectado del género Lutzomyia. Diversos estudios han concluido que las tasas reales de incidencia de Leishmaniasis son sustancialmente altas en todo el mundo y su prevalencia es alta en países de las Américas. En el presente artículo, se muestra el resultado de una revisión documental la cual se enfoca en realizar una descripción de las especies del protozoario del género Leishmania en las Américas, se caracteriza clínicamente la Leishmaniasis cutánea y visceral, y se muestra una clasificación taxonómica de Leishmania en el continente. Adicionalmente, se trata el ciclo de vida del parásito protozoario, los vectores, y algunos aspectos epidemiológicosn acerca de las formas clínicas que componen la Leishmanias. Se consideró el método de revisión documental, a través de la técnica de análisis de contenido para el desarrollo del presente trabajo.spa
dc.description.abstractLeishmaniasis is a disease caused by a protozoan parasite of the genus Leishmania. It is considered an indigenous disease of slow progression, and epidemiologically treated in the Americas, as a parasitic disorder transmitted by the sting of an infected hematófago mosquito of the genus Lutzomyia. Several studies have concluded that the actual incidence rates of Leishmaniasis are substantially high worldwide and their prevalence is high in countries in the Americas. This article shows the result of a documentary review which focuses on making a description of the species of protozoan of the genus Leishmania in the Americas, cutaneous and visceral Leishmaniasis is characterized clinically, and is shown A taxonomic classification of Leishmania in the continent. In addition, it treats the life cycle of the parasite protozoan, vectors, and some aspects epidemiológicosn about the clinical forms that make up Leishmania. The method of documentary review was considered, through the technique of content analysis for the development of this work.eng
dc.identifier.issn26107988
dc.identifier.urihttp://hdl.handle.net/20.500.12442/2305
dc.language.isospaspa
dc.publisherSociedad Venezolana de Farmacología Clínica y Terapéuticaspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.licenseLicencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacionalspa
dc.sourceRevista AVFT-Archivos Venezolanos de Farmacología y Terapéuticaspa
dc.sourceVol. 37, No. 3 (2018)spa
dc.source.urihttp://www.revistaavft.com/images/revistas/2018/avft_3_2018/4_una_vision_acerca.pdfspa
dc.subjectLeishmaniasisspa
dc.subjectLeishmaniasis cutáneaspa
dc.subjectLeishmaniasis visceralspa
dc.subjectMosquito hematófago del género Lutzomyiaspa
dc.subjectLeishmaniasis Cutaneouseng
dc.subjectHematophagous mosquito of the genus Lutzomyiaeng
dc.titleUna visión acerca de la Leishmaniasis americana y de su comportamiento epidemiológicospa
dc.title.alternativeA vision about American Leishmaniasis and its epidemiological behavioreng
dc.typearticlespa
dcterms.referencesRamírez J, Hernández C, León C, Ayala M, Flórez C, González C. Taxonomy, diversity, temporal and geographical distribution of Cutaneous Leishmaniasis in Colombia: A retrospective study. [Internet]. 2016. Available from: http://www. nature.com/articles/srep28266eng
dcterms.referencesKevric I, Cappel M, Keeling J. New World and Old World Leishmania Infections: A Practical Review. Dermatol Clin. 2015;33(3):579–93.eng
dcterms.referencesHerwaldt B. Leishmaniasis, The Lancet. 1999;354(9185):1191–9.eng
dcterms.referencesWorld-Health-Organization. Informe de una reunión del Comité de Expertos de la OMS sobre el control de las leishmaniasis, Serie de informes técnicos No. 949. 2012;spa
dcterms.referencesBerman J. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis. 1997;24(4):684–703.eng
dcterms.referencesPearson R, Queiroz Sousa A. Clinical Spectrum of Leishmaniasis. Clin Infect Dis. 1996;22(1):1–11.eng
dcterms.referencesWorld-Health-Assembly. The World Health Assembly Resolution (WHA60.13) on the “Control of leishmaniasis”. Geneva, Switzerland; 2007.eng
dcterms.referencesBailey M, Lockwood D. Cutaneous leishmaniasis. Clin Dermatol. 2007;25(2):203–11.eng
dcterms.referencesSangueza OP, Sangueza JM, Stiller MJ, Sangueza P. Mucocutaneous leishmaniasis: A clinicopathologic classification. J Am Acad Dermatol [Internet]. 1993;28(6):927–32. Available from: http://dx.doi.org/10.1016/0190- 9622(93)70132-Deng
dcterms.referencesReady P. Epidemiology of visceral leishmaniasis. Clin Epidemiol. 2014;6(3):147–54.eng
dcterms.referencesSatoskar A, Durvasula R. Pathogenesis of Leishmaniasis: New Developments in Research. Springer. 2014.eng
dcterms.referencesGrevelink S, Lerner E. Leishmaniasis. J Am Acad Dermatol. 1996;34(2):257–72.eng
dcterms.referencesAlvar J, Vélez I, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis Worldwide and Global Estimates of Its Incidence. PLoS One. 2012;7(5).eng
dcterms.referencesWorld-Health-Organization, Pan-American-Health-Organization. Leishmaniasis: Informe Epidemiológico de las Américas, Informes de Leishmaniasis No. 6. 2018.eng
dcterms.referencesPigott D, Bhatt S, Golding N, Duda K, Battle K, Brady O, et al. Global distribution maps of the Leishmaniases. Elife. 2014;3(1):21.eng
dcterms.referencesMelchior L, Brilhante A, Chiaravalloti-Neto F. Spatial and temporal distribution of American cutaneous leishmaniasis in Acre state, Brazil. Infect Dis Poverty. 2017;6(1):99.eng
dcterms.referencesMontero M, Hochman E. Investigación Documental: Técnicas y Procedimientos. Venezuela: Panapo; 2005.spa
dcterms.referencesSandín M. Investigación cualitativa en educación. Fundamentos y tradiciones. Madrid: McGRAW-Hill/Interamericana de España; 2003.spa
dcterms.referencesMarcili A, Sperança MA, da Costa AP, Madeira M de F, Soares HS, Sanches C de OCC, et al. Phylogenetic relationships of Leishmania species based on trypanosomatid barcode (SSU rDNA) and gGAPDH genes: Taxonomic revision of Leishmania (L.) infantum chagasi in South America. Infect Genet Evol [Internet]. 2014;25:44–51. Available from: http://dx.doi.org/10.1016/j.meegid.2014.04.001eng
dcterms.referencesWorld-Health-Organization. Control of Leishmaniases. Geneva; 1990.eng
dcterms.referencesBates PA. Revising Leishmania’s life cycle. Nat Microbiol [Internet]. 2018;3(5):529–30. Available from: http://dx.doi.org/10.1038/s41564-018-0154-2eng
dcterms.referencesSerafim TD, Coutinho-Abreu I V., Oliveira F, Meneses C, Kamhawi S, Valenzuela JG. Sequential blood meals promote Leishmania replication and reverse metacyclogenesis augmenting vector infectivity. Nat Microbiol [Internet]. 2018;3(5):548–55. Available from: http://dx.doi.org/10.1038/s41564-018-0125-7eng
dcterms.referencesSchlein Y, Jacobson R, Messer G. Leishmania infections damage the feeding mechanism of the sandfly vector and implement parasite transmission by bite. Proc Natl Acad Sci U S A. 1992;89(20):9944–9948.eng
dcterms.referencesRogers M, Ilg T, Nikolaev A, Ferguson M, Bates P. Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. Nature. 2004;430(6998):463–467.eng
dcterms.referencesBates P. Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. Int J Parasitol. 2007;37(10–3):1097–1106.eng
dcterms.referencesSacks D, Perkins P. Identification of an infective stage of Leishmania promastigotes. Science (80- ). 1984;223(4643):1417–9.eng
dcterms.referencesClaborn D. The Biology and Control of Leishmaniasis Vectors. J Glob Infect Dis. 2010;2(2):127–134.eng
dcterms.referencesLlanos A, Naquira C. Leishmaniasis. Parasitolo. Santiago de Chile; 1998. 242- 250. p.spa
dcterms.referencesRoque A, Jansen A. Wild and synanthropic reservoirs of Leishmania species in the Americas, International. J Parasitol Parasites Wildl. 2014;3(3):251–62.eng
dcterms.referencesAkhoundi M, Kuhls K, Cannet A, Votýpka J, Marty P, Delaunay P, et al. A Historical Overview of the Classification, Evolution, and Dispersion of Leishmania Parasites and Sandflies. PLoS Negl Trop Dis. 2016;10(3).eng
dcterms.referencesFarrell J. Leishmania. Volume 4 de World Class Parasites. Springer S. Springer US; 2002.eng
dcterms.referencesde Ruiter CM, van der Veer C, Leeflang MMG, Deborggraeve S, Lucas C, Adams ER. Molecular Tools for Diagnosis of Visceral Leishmaniasis: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. J Clin Microbiol [Internet]. 2014;52(9):3147–55. Available from: http://jcm.asm.org/lookup/ doi/10.1128/JCM.00372-14eng
dcterms.referencesBacellar O, Lessa H, Schriefer A, Machado P, De Jesus AR, Dutra WO, et al. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun. 2002;70(12):6734–40.eng
dcterms.referencesSilva N, Ponte-Sucre A. ABC Proteins In Leishmania Mexicana: Modulation of Parasite-Host Cell Interaction. Arch Venez Farmacol y Ter [Internet]. 2001;20(2):134–8. Available from: http://www.scielo.org.ve/scielo. php?pid=S0798-02642001000200006&script=sci_arttexteng
dcterms.referencesScott P, Novais FO. Cutaneous leishmaniasis: Immune responses in protection and pathogenesis. Nat Rev Immunol [Internet]. 2016;16(9):581–92. Available from: http://dx.doi.org/10.1038/nri.2016.72eng
dcterms.referencesVega-López F. Diagnosis of cutaneous leishmaniasis. Curr Opin Infect Dis. 2003;16(2):97–101.eng
dcterms.referencesEspir T, Guerreiro T, Naiff M, Figueira L, Soares F, da Silva S, et al. Evaluation of different diagnostic methods of American Cutaneous Leishmaniasis in the Brazilian Amazon. Exp Parasitol. 2016;167:1–6.eng
dcterms.referencesSoares K, Ayala A, dos Santos G, Lisboa Carneiro A, Martins Gomes C, Roselino A, et al. Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance, The Brazilian. J Infect Dis. 2015;19(3):302–7.eng
dcterms.referencesPadrón-Nieves M, Ponte-Sucre A. Marcadores de resistencia en Leishmania: Susceptibilidad in vitro a drogas leishmanicidas vs retención de calceina en aislados de pacientes venezolanos con Leishmaniasis Cutánea Difusa. Arch Venez Farmacol y Ter. 2015;34(4):53–57.eng
dcterms.referencesFigarella K, Uzcátegui N, García N, Silva N, Camacho N, Ponte-Sucre A. Molecular Pharmacology of Chemo-Resistant Leishmania. Arch Venez Farmacol y Ter [Internet]. 2003;22(1):19–24. Available from: http://www.scielo.org.ve/scielo. php?pid=S0798-02642003000100004&script=sci_abstract&tlng=eneng
dcterms.referencesVásquez L, Scorza J, Vicuña-Fernández N, Petit Y, Bendezú H, Vasquez L. Influence of gentamicine on the pharmacokinetic of a pentavalent antimonial compound Glucantime Influence of gentamicine on Glucantime kinetic. Arch Venez Farmacol y Ter. 2006;25(2):60–3.eng

Archivos

Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
368 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos

Universidad Simón Bolívar: Todos los derechos reservados / Sistema de biblioteca